1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Upper Urinary Tract Infection 1.2.3 Lower Urinary Tract Infection 1.3 Market by Application 1.3.1 Global Urinary Tract Infection (UTI) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Self-administered 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Urinary Tract Infection (UTI) Market Perspective (2016-2027) 2.2 Urinary Tract Infection (UTI) Growth Trends by Regions 2.2.1 Urinary Tract Infection (UTI) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Urinary Tract Infection (UTI) Historic Market Share by Regions (2016-2021) 2.2.3 Urinary Tract Infection (UTI) Forecasted Market Size by Regions (2022-2027) 2.3 Urinary Tract Infection (UTI) Industry Dynamic 2.3.1 Urinary Tract Infection (UTI) Market Trends 2.3.2 Urinary Tract Infection (UTI) Market Drivers 2.3.3 Urinary Tract Infection (UTI) Market Challenges 2.3.4 Urinary Tract Infection (UTI) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Urinary Tract Infection (UTI) Players by Revenue 3.1.1 Global Top Urinary Tract Infection (UTI) Players by Revenue (2016-2021) 3.1.2 Global Urinary Tract Infection (UTI) Revenue Market Share by Players (2016-2021) 3.2 Global Urinary Tract Infection (UTI) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Urinary Tract Infection (UTI) Revenue 3.4 Global Urinary Tract Infection (UTI) Market Concentration Ratio 3.4.1 Global Urinary Tract Infection (UTI) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Urinary Tract Infection (UTI) Revenue in 2020 3.5 Urinary Tract Infection (UTI) Key Players Head office and Area Served 3.6 Key Players Urinary Tract Infection (UTI) Product Solution and Service 3.7 Date of Enter into Urinary Tract Infection (UTI) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Urinary Tract Infection (UTI) Breakdown Data by Type 4.1 Global Urinary Tract Infection (UTI) Historic Market Size by Type (2016-2021) 4.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2022-2027) 5 Urinary Tract Infection (UTI) Breakdown Data by Application 5.1 Global Urinary Tract Infection (UTI) Historic Market Size by Application (2016-2021) 5.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Urinary Tract Infection (UTI) Market Size (2016-2027) 6.2 North America Urinary Tract Infection (UTI) Market Size by Type 6.2.1 North America Urinary Tract Infection (UTI) Market Size by Type (2016-2021) 6.2.2 North America Urinary Tract Infection (UTI) Market Size by Type (2022-2027) 6.2.3 North America Urinary Tract Infection (UTI) Market Size by Type (2016-2027) 6.3 North America Urinary Tract Infection (UTI) Market Size by Application 6.3.1 North America Urinary Tract Infection (UTI) Market Size by Application (2016-2021) 6.3.2 North America Urinary Tract Infection (UTI) Market Size by Application (2022-2027) 6.3.3 North America Urinary Tract Infection (UTI) Market Size by Application (2016-2027) 6.4 North America Urinary Tract Infection (UTI) Market Size by Country 6.4.1 North America Urinary Tract Infection (UTI) Market Size by Country (2016-2021) 6.4.2 North America Urinary Tract Infection (UTI) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Urinary Tract Infection (UTI) Market Size (2016-2027) 7.2 Europe Urinary Tract Infection (UTI) Market Size by Type 7.2.1 Europe Urinary Tract Infection (UTI) Market Size by Type (2016-2021) 7.2.2 Europe Urinary Tract Infection (UTI) Market Size by Type (2022-2027) 7.2.3 Europe Urinary Tract Infection (UTI) Market Size by Type (2016-2027) 7.3 Europe Urinary Tract Infection (UTI) Market Size by Application 7.3.1 Europe Urinary Tract Infection (UTI) Market Size by Application (2016-2021) 7.3.2 Europe Urinary Tract Infection (UTI) Market Size by Application (2022-2027) 7.3.3 Europe Urinary Tract Infection (UTI) Market Size by Application (2016-2027) 7.4 Europe Urinary Tract Infection (UTI) Market Size by Country 7.4.1 Europe Urinary Tract Infection (UTI) Market Size by Country (2016-2021) 7.4.2 Europe Urinary Tract Infection (UTI) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size (2016-2027) 8.2 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type 8.2.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2016-2027) 8.3 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application 8.3.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2016-2027) 8.4 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region 8.4.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Urinary Tract Infection (UTI) Market Size (2016-2027) 9.2 Latin America Urinary Tract Infection (UTI) Market Size by Type 9.2.1 Latin America Urinary Tract Infection (UTI) Market Size by Type (2016-2021) 9.2.2 Latin America Urinary Tract Infection (UTI) Market Size by Type (2022-2027) 9.2.3 Latin America Urinary Tract Infection (UTI) Market Size by Type (2016-2027) 9.3 Latin America Urinary Tract Infection (UTI) Market Size by Application 9.3.1 Latin America Urinary Tract Infection (UTI) Market Size by Application (2016-2021) 9.3.2 Latin America Urinary Tract Infection (UTI) Market Size by Application (2022-2027) 9.3.3 Latin America Urinary Tract Infection (UTI) Market Size by Application (2016-2027) 9.4 Latin America Urinary Tract Infection (UTI) Market Size by Country 9.4.1 Latin America Urinary Tract Infection (UTI) Market Size by Country (2016-2021) 9.4.2 Latin America Urinary Tract Infection (UTI) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size (2016-2027) 10.2 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type 10.2.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2016-2027) 10.3 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application 10.3.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2016-2027) 10.4 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country 10.4.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis AG 11.1.1 Novartis AG Company Details 11.1.2 Novartis AG Business Overview 11.1.3 Novartis AG Urinary Tract Infection (UTI) Introduction 11.1.4 Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.1.5 Novartis AG Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Company Details 11.2.2 GlaxoSmithKline Business Overview 11.2.3 GlaxoSmithKline Urinary Tract Infection (UTI) Introduction 11.2.4 GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.2.5 GlaxoSmithKline Recent Development 11.3 Dr. Reddy’s Laboratories Ltd., 11.3.1 Dr. Reddy’s Laboratories Ltd., Company Details 11.3.2 Dr. Reddy’s Laboratories Ltd., Business Overview 11.3.3 Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Introduction 11.3.4 Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.3.5 Dr. Reddy’s Laboratories Ltd., Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Urinary Tract Infection (UTI) Introduction 11.4.4 Pfizer Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 Roche 11.5.1 Roche Company Details 11.5.2 Roche Business Overview 11.5.3 Roche Urinary Tract Infection (UTI) Introduction 11.5.4 Roche Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.5.5 Roche Recent Development 11.6 AstraZeneca, 11.6.1 AstraZeneca, Company Details 11.6.2 AstraZeneca, Business Overview 11.6.3 AstraZeneca, Urinary Tract Infection (UTI) Introduction 11.6.4 AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.6.5 AstraZeneca, Recent Development 11.7 Cipla 11.7.1 Cipla Company Details 11.7.2 Cipla Business Overview 11.7.3 Cipla Urinary Tract Infection (UTI) Introduction 11.7.4 Cipla Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.7.5 Cipla Recent Development 11.8 Johnson & Johnson 11.8.1 Johnson & Johnson Company Details 11.8.2 Johnson & Johnson Business Overview 11.8.3 Johnson & Johnson Urinary Tract Infection (UTI) Introduction 11.8.4 Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.8.5 Johnson & Johnson Recent Development 11.9 Bayer AG 11.9.1 Bayer AG Company Details 11.9.2 Bayer AG Business Overview 11.9.3 Bayer AG Urinary Tract Infection (UTI) Introduction 11.9.4 Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.9.5 Bayer AG Recent Development 11.10 Teva Pharmaceutical Industries 11.10.1 Teva Pharmaceutical Industries Company Details 11.10.2 Teva Pharmaceutical Industries Business Overview 11.10.3 Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Introduction 11.10.4 Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.10.5 Teva Pharmaceutical Industries Recent Development 11.11 Boehringer Ingelheim 11.11.1 Boehringer Ingelheim Company Details 11.11.2 Boehringer Ingelheim Business Overview 11.11.3 Boehringer Ingelheim Urinary Tract Infection (UTI) Introduction 11.11.4 Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.11.5 Boehringer Ingelheim Recent Development 11.12 Sanofi 11.12.1 Sanofi Company Details 11.12.2 Sanofi Business Overview 11.12.3 Sanofi Urinary Tract Infection (UTI) Introduction 11.12.4 Sanofi Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.12.5 Sanofi Recent Development 11.13 Lily 11.13.1 Lily Company Details 11.13.2 Lily Business Overview 11.13.3 Lily Urinary Tract Infection (UTI) Introduction 11.13.4 Lily Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.13.5 Lily Recent Development 11.14 Abbott 11.14.1 Abbott Company Details 11.14.2 Abbott Business Overview 11.14.3 Abbott Urinary Tract Infection (UTI) Introduction 11.14.4 Abbott Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.14.5 Abbott Recent Development 11.15 JinShuiBao 11.15.1 JinShuiBao Company Details 11.15.2 JinShuiBao Business Overview 11.15.3 JinShuiBao Urinary Tract Infection (UTI) Introduction 11.15.4 JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.15.5 JinShuiBao Recent Development 11.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) 11.16.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details 11.16.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview 11.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Introduction 11.16.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development 11.17 Sinopharm 11.17.1 Sinopharm Company Details 11.17.2 Sinopharm Business Overview 11.17.3 Sinopharm Urinary Tract Infection (UTI) Introduction 11.17.4 Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.17.5 Sinopharm Recent Development 11.18 Borui Medicine 11.18.1 Borui Medicine Company Details 11.18.2 Borui Medicine Business Overview 11.18.3 Borui Medicine Urinary Tract Infection (UTI) Introduction 11.18.4 Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.18.5 Borui Medicine Recent Development 11.18 Zhejiang Xianju Pharmaceutical .1 Zhejiang Xianju Pharmaceutical Company Details .2 Zhejiang Xianju Pharmaceutical Business Overview .3 Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Introduction .4 Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) .5 Zhejiang Xianju Pharmaceutical Recent Development 11.20 Sichuan Guorui Pharmaceutical 11.20.1 Sichuan Guorui Pharmaceutical Company Details 11.20.2 Sichuan Guorui Pharmaceutical Business Overview 11.20.3 Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Introduction 11.20.4 Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.20.5 Sichuan Guorui Pharmaceutical Recent Development 11.21 Hengrui Pharmaceutical 11.21.1 Hengrui Pharmaceutical Company Details 11.21.2 Hengrui Pharmaceutical Business Overview 11.21.3 Hengrui Pharmaceutical Urinary Tract Infection (UTI) Introduction 11.21.4 Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) 11.21.5 Hengrui Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Upper Urinary Tract Infection Table 3. Key Players of Lower Urinary Tract Infection Table 4. Global Urinary Tract Infection (UTI) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Urinary Tract Infection (UTI) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Urinary Tract Infection (UTI) Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Urinary Tract Infection (UTI) Market Share by Regions (2016-2021) Table 8. Global Urinary Tract Infection (UTI) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Urinary Tract Infection (UTI) Market Share by Regions (2022-2027) Table 10. Urinary Tract Infection (UTI) Market Trends Table 11. Urinary Tract Infection (UTI) Market Drivers Table 12. Urinary Tract Infection (UTI) Market Challenges Table 13. Urinary Tract Infection (UTI) Market Restraints Table 14. Global Urinary Tract Infection (UTI) Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Urinary Tract Infection (UTI) Market Share by Players (2016-2021) Table 16. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection (UTI) as of 2020) Table 17. Ranking of Global Top Urinary Tract Infection (UTI) Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Urinary Tract Infection (UTI) Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Urinary Tract Infection (UTI) Product Solution and Service Table 21. Date of Enter into Urinary Tract Infection (UTI) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million) Table 24. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2016-2021) Table 25. Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Urinary Tract Infection (UTI) Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Urinary Tract Infection (UTI) Revenue Market Share by Application (2016-2021) Table 29. Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Urinary Tract Infection (UTI) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million) Table 32. North America Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million) Table 34. North America Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Urinary Tract Infection (UTI) Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Urinary Tract Infection (UTI) Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Urinary Tract Infection (UTI) Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Urinary Tract Infection (UTI) Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Urinary Tract Infection (UTI) Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Urinary Tract Infection (UTI) Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2022-2027) & (US$ Million) Table 61. Novartis AG Company Details Table 62. Novartis AG Business Overview Table 63. Novartis AG Urinary Tract Infection (UTI) Product Table 64. Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 65. Novartis AG Recent Development Table 66. GlaxoSmithKline Company Details Table 67. GlaxoSmithKline Business Overview Table 68. GlaxoSmithKline Urinary Tract Infection (UTI) Product Table 69. GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 70. GlaxoSmithKline Recent Development Table 71. Dr. Reddy’s Laboratories Ltd., Company Details Table 72. Dr. Reddy’s Laboratories Ltd., Business Overview Table 73. Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Product Table 74. Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 75. Dr. Reddy’s Laboratories Ltd., Recent Development Table 76. Pfizer Company Details Table 77. Pfizer Business Overview Table 78. Pfizer Urinary Tract Infection (UTI) Product Table 79. Pfizer Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 80. Pfizer Recent Development Table 81. Roche Company Details Table 82. Roche Business Overview Table 83. Roche Urinary Tract Infection (UTI) Product Table 84. Roche Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 85. Roche Recent Development Table 86. AstraZeneca, Company Details Table 87. AstraZeneca, Business Overview Table 88. AstraZeneca, Urinary Tract Infection (UTI) Product Table 89. AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 90. AstraZeneca, Recent Development Table 91. Cipla Company Details Table 92. Cipla Business Overview Table 93. Cipla Urinary Tract Infection (UTI) Product Table 94. Cipla Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 95. Cipla Recent Development Table 96. Johnson & Johnson Company Details Table 97. Johnson & Johnson Business Overview Table 98. Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 99. Johnson & Johnson Recent Development Table 100. Bayer AG Company Details Table 101. Bayer AG Business Overview Table 102. Bayer AG Urinary Tract Infection (UTI) Product Table 103. Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 104. Bayer AG Recent Development Table 105. Teva Pharmaceutical Industries Company Details Table 106. Teva Pharmaceutical Industries Business Overview Table 107. Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Product Table 108. Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 109. Teva Pharmaceutical Industries Recent Development Table 110. Boehringer Ingelheim Company Details Table 111. Boehringer Ingelheim Business Overview Table 112. Boehringer Ingelheim Urinary Tract Infection (UTI) Product Table 113. Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 114. Boehringer Ingelheim Recent Development Table 115. Sanofi Company Details Table 116. Sanofi Business Overview Table 117. Sanofi Urinary Tract Infection (UTI) Product Table 118. Sanofi Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 119. Sanofi Recent Development Table 120. Lily Company Details Table 121. Lily Business Overview Table 122. Lily Urinary Tract Infection (UTI) Product Table 123. Lily Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 124. Lily Recent Development Table 125. Abbott Company Details Table 126. Abbott Business Overview Table 127. Abbott Urinary Tract Infection (UTI) Product Table 128. Abbott Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 129. Abbott Recent Development Table 130. JinShuiBao Company Details Table 131. JinShuiBao Business Overview Table 132. JinShuiBao Urinary Tract Infection (UTI) Product Table 133. JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 134. JinShuiBao Recent Development Table 135. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details Table 136. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview Table 137. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Product Table 138. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 139. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development Table 140. Sinopharm Company Details Table 141. Sinopharm Business Overview Table 142. Sinopharm Urinary Tract Infection (UTI) Product Table 143. Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 144. Sinopharm Recent Development Table 145. Borui Medicine Company Details Table 146. Borui Medicine Business Overview Table 147. Borui Medicine Urinary Tract Infection (UTI) Product Table 148. Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 149. Borui Medicine Recent Development Table 150. Zhejiang Xianju Pharmaceutical Company Details Table 151. Zhejiang Xianju Pharmaceutical Business Overview Table 152. Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Product Table 153. Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 154. Zhejiang Xianju Pharmaceutical Recent Development Table 155. Sichuan Guorui Pharmaceutical Company Details Table 156. Sichuan Guorui Pharmaceutical Business Overview Table 157. Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Product Table 158. Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 159. Sichuan Guorui Pharmaceutical Recent Development Table 160. Hengrui Pharmaceutical Company Details Table 161. Hengrui Pharmaceutical Business Overview Table 162. Hengrui Pharmaceutical Urinary Tract Infection (UTI) Product Table 163. Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2016-2021) & (US$ Million) Table 164. Hengrui Pharmaceutical Recent Development Table 165. Research Programs/Design for This Report Table 166. Key Data Information from Secondary Sources Table 167. Key Data Information from Primary Sources List of Figures Figure 1. Global Urinary Tract Infection (UTI) Market Share by Type: 2020 VS 2027 Figure 2. Upper Urinary Tract Infection Features Figure 3. Lower Urinary Tract Infection Features Figure 4. Global Urinary Tract Infection (UTI) Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Clinic Case Studies Figure 7. Self-administered Case Studies Figure 8. Others Case Studies Figure 9. Urinary Tract Infection (UTI) Report Years Considered Figure 10. Global Urinary Tract Infection (UTI) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Urinary Tract Infection (UTI) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Urinary Tract Infection (UTI) Market Share by Regions: 2020 VS 2027 Figure 13. Global Urinary Tract Infection (UTI) Market Share by Regions (2022-2027) Figure 14. Global Urinary Tract Infection (UTI) Market Share by Players in 2020 Figure 15. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urinary Tract Infection (UTI) as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Urinary Tract Infection (UTI) Revenue in 2020 Figure 17. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2016-2021) Figure 18. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2022-2027) Figure 19. North America Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Urinary Tract Infection (UTI) Market Share by Type (2016-2027) Figure 21. North America Urinary Tract Infection (UTI) Market Share by Application (2016-2027) Figure 22. North America Urinary Tract Infection (UTI) Market Share by Country (2016-2027) Figure 23. United States Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Urinary Tract Infection (UTI) Market Share by Type (2016-2027) Figure 27. Europe Urinary Tract Infection (UTI) Market Share by Application (2016-2027) Figure 28. Europe Urinary Tract Infection (UTI) Market Share by Country (2016-2027) Figure 29. Germany Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Urinary Tract Infection (UTI) Market Share by Type (2016-2027) Figure 37. Asia-Pacific Urinary Tract Infection (UTI) Market Share by Application (2016-2027) Figure 38. Asia-Pacific Urinary Tract Infection (UTI) Market Share by Region (2016-2027) Figure 39. China Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Urinary Tract Infection (UTI) Market Share by Type (2016-2027) Figure 47. Latin America Urinary Tract Infection (UTI) Market Share by Application (2016-2027) Figure 48. Latin America Urinary Tract Infection (UTI) Market Share by Country (2016-2027) Figure 49. Mexico Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Urinary Tract Infection (UTI) Market Share by Type (2016-2027) Figure 53. Middle East & Africa Urinary Tract Infection (UTI) Market Share by Application (2016-2027) Figure 54. Middle East & Africa Urinary Tract Infection (UTI) Market Share by Country (2016-2027) Figure 55. Turkey Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Urinary Tract Infection (UTI) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Novartis AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 59. GlaxoSmithKline Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 60. Dr. Reddy’s Laboratories Ltd., Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 61. Pfizer Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 62. Roche Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 63. AstraZeneca, Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 64. Cipla Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 65. Johnson & Johnson Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 66. Bayer AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 68. Boehringer Ingelheim Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 69. Sanofi Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 70. Lily Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 71. Abbott Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 72. JinShuiBao Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 73. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 74. Sinopharm Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 75. Borui Medicine Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 76. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 77. Sichuan Guorui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 78. Hengrui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2016-2021) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

Novartis AG GlaxoSmithKline Dr. Reddy’s Laboratories Ltd., Pfizer Roche AstraZeneca, Cipla Johnson & Johnson Bayer AG Teva Pharmaceutical Industries Boehringer Ingelheim Sanofi Lily Abbott JinShuiBao Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Sinopharm Borui Medicine Zhejiang Xianju Pharmaceutical Sichuan Guorui Pharmaceutical Hengrui Pharmaceutical